CUHK reveals a potential treatment target for glaucoma that can restore 70% of lost vision in animal models. A pioneering breakthrough in neuroprotection therapy
Chinese University of Hong Kong
22nd June 2026
CUHK reveals a potential treatment target for glaucoma that can restore 70% of lost vision in animal models. A pioneering breakthrough in neuroprotection therapy
The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine (CU Medicine) has identified the growth hormone-releasing hormone receptor (GHRHR) as a new potential therapeutic target for glaucoma, which could eventually lead to a breakthrough in neuroprotection treatment for this important disease. The inhibition of this receptor protein in eye tissues has enhanced the survival of retinal ganglion cells (RGCs) and protected the optic nerve from degeneration and death in experimental animal glaucoma models, resulting in the recovery of nearly 70% of lost vision in these animal models. The groundbreaking findings address limitations of current therapies, offering new hope for glaucoma patients worldwide. The research has been published in the leading international scientific journal "Advanced Science".
High blindness rate persists as vision loss remains incurable
Comments